| Literature DB >> 28751300 |
Martin Cernvall1, Per Carlbring2, Anna Wikman1, Lisa Ljungman1, Gustaf Ljungman3, Louise von Essen1.
Abstract
BACKGROUND: A substantial proportion of parents of children on cancer treatment report psychological distress such as symptoms of post-traumatic stress (PTSS), depression, and anxiety. During their child's treatment many parents also experience an economic burden.Entities:
Keywords: Internet; PTSS; anxiety; cancer; clinical trial; depression; parents
Mesh:
Year: 2017 PMID: 28751300 PMCID: PMC5553001 DOI: 10.2196/jmir.6852
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Consort diagram of participant flow through the study.
Baseline characteristics of parents.
| Characteristics | Total sample | Intervention | Wait-list | ||
| Mothers, n (%) | 39 (67) | 21 (68) | 18 (67) | .76 | |
| Partner also included in study, n (%) | 22 (38) | 12 (39) | 10 (37) | .90 | |
| Age, mean (SDa) | 38 (7.2)b | 40 (7.4)c | 36 (6.6)d | .06 | |
| Living with child’s biological parent, n (%) | 51 (88) | 26 (84) | 25 (93) | .31 | |
| Completed university studies, n (%) | 30 (52) | 17 (55) | 13 (48) | .61 | |
| In active employment, n (%) | 47 (81) | 26 (84) | 21 (78) | .56 | |
| Median distance in km to POCe (IQRf) | 35 (61) | 39 (62) | 20 (50) | .39 | |
| Experience of previous traumatic event(s), n (%) | 26 (45) | 14 (45) | 12 (44) | .96 | |
| Median months since child´s dxg (IQR) | 3.0 (3.0)h | 3.0 (2.25)i | 3.0 (3.0) | .39 | |
| PCL-Cj | 49.1 (10.3) | 51.5 (9.4) | 46.6 (10.7) | .06 | |
| BDI-IIk | 20.6 (7.5) | 21.6 (8.1) | 19.3 (6.7) | .24 | |
| BAIl | 14.7 (7.6) | 17.2 (7.8) | 11.9 (6.3) | <.01 | |
aSD: standard deviation.
bn=55.
cn=29.
dn=26.
ePOC: pediatric oncology center.
fIQR: interquartile range.
gdx: diagnosis.
hn=57.
in=30.
jPCL-C: PTSD-Checklist-Civilian version.
kBDI-II: Beck Depression Inventory-II.
lBAI: Beck Anxiety Inventory.
Baseline characteristics of children.
| Characteristics | Total sample | Intervention | Wait-list | ||
| Female, n (%) | 25 (54) | 16 (64) | 9 (43) | .15 | |
| Median age (IQRa) | 5 (9.0) | 6 (10.5) | 4 (8.0) | .26 | |
| .33 | |||||
| Leukemia | 24 (52) | 13 (52) | 11 (52) | ||
| Sarcoma | 8 (17) | 5 (20) | 3 (14) | ||
| Lymphoma | 3 (7) | 3 (12) | 0 (0) | ||
| CNSb-tumor | 7 (15) | 2 (8) | 5 (24) | ||
| Other malignant disease | 4 (9) | 2 (8) | 2 (10) | ||
aIQR: interquartile range.
bCNS: central nervous system.
Estimated outcomes of mixed effects models and effect sizes (n=58 in intention-to-treat analyses). Cohen d is the standardized mean difference and was calculated using the estimated mean difference and the standard deviation of the complete sample at the preassessment.
| Outcome | Degrees of freedom | Estimate (SEa) | 95% CI | |||||
| Intercept | 1, 66.6 | 46.26 (2.09) | 42.08-50.44 | 488.11 | 22.10 | <.001 | ||
| Group | 1, 66.6 | 5.22 (2.86) | −0.49 to 10.94 | 3.33 | 1.82 | .07 | ||
| Linear | 1, 58.0 | −2.29 (4.06) | −10.42 to 5.84 | 0.32 | −0.56 | .57 | ||
| Quadratic | 1, 52.1 | 1.11 (2.00) | −2.90 to 5.14 | 0.31 | 0.56 | .58 | ||
| Linear × Group | 1, 59.2 | −21.87 (5.92) | −33.73 to −10.02 | 13.63 | −3.70 | <.001 | ||
| Quadratic × Group | 1, 50.8 | 7.47 (2.90) | 1.63-13.30 | 6.61 | 2.57 | .01 | ||
| Difference POST | −9.16 (3.50) | −16.09 to −2.23 | 6.86 | .01 | ||||
| 0.89 | 0.35-1.43 | |||||||
| Difference 12mFU | −8.07 (3.67) | −15.33 to −0.8 | 4.84 | .03 | ||||
| 0.78 | 0.25-1.32 | |||||||
| Intercept | 1, 63.9 | 19.33 (1.45) | 16.43-22.22 | 177.50 | 13.32 | <.001 | ||
| Group | 1, 64.2 | 1.62 (1.99] | −2.36 to 5.59 | 0.66 | 0.81 | .42 | ||
| Linear | 1, 37.5 | 0.41 (0.92) | −1.47 to 2.28 | 0.19 | 0.44 | .66 | ||
| Quadratic | - | - | - | |||||
| Linear × Group | 1, 36.1 | −5.58 (1.31) | −8.23 to −2.92 | 18.12 | −4.26 | <.001 | ||
| Quadratic × Group | - | - | - | |||||
| Difference POST | −3.91 (1.89) | −7.68 to −0.13 | 4.29 | .04 | ||||
| 0.52 | −0.003 to 1.04 | |||||||
| Difference 12mFU | −9.41 (2.49) | −14.34 to −4.48 | 14.31 | <.001 | ||||
| 1.25 | 0.69-1.82 | |||||||
| Intercept | 1, 57.8 | 11.48 (1.52) | 8.44-14.51 | 57.36 | 7.57 | <.001 | ||
| Group | 1, 57.9 | 5.11 (2.08) | 0.95-9.26 | 6.06 | 2.5 | .02 | ||
| Linear | 1, 33.0 | 1.84 (0.83) | 0.15-3.52 | 4.93 | 2.2 | .03 | ||
| Quadratic | - | - | - | |||||
| Linear × Group | 1, 32.2 | −6.06 (1.17) | −8.44 to −3.67 | 26.80 | −5.2 | <.001 | ||
| Quadratic × Group | - | - | - | |||||
| Difference POST | 0.94 (1.98) | −4.91 to 3.03 | 0.23 | .23 | ||||
| 0.12 | −0.39 to 0.64 | |||||||
| Difference 12mFU | −6.99(2.50) | −11.94 to −2.04 | 7.85 | .006 | ||||
| 0.92 | 0.38-1.46 | |||||||
aSE: standard error.
bPCL-C: PTSD-Checklist-Civilian version.
cBDI-II: Beck Depression Inventory-II.
dBAI: Beck Anxiety Inventory.
Figure 2Estimated outcomes from mixed models with continuous variables.